|Coordinate||66,859,847 bp (GRCm38)|
|Base Change||A ⇒ T (forward strand)|
|Gene Name||melanocortin 4 receptor|
|Chromosomal Location||66,857,715-66,860,472 bp (-)|
FUNCTION: This gene encodes a member of the melanocortin receptor family. Melanocortin receptors are transmembrane G-protein coupled receptors, which respond to small peptide hormones and exhibit diverse functions and tissue type localization. As part of the central nervous melanocortin system, the encoded protein is competitively bound by either melanocyte stimulating hormone or agouti-related protein to regulate energy homeostasis. Disruption of this gene promotes hyperphagia and obesity, and is associated with increased cholesterol levels and insulin resistance. [provided by RefSeq, Dec 2012]
PHENOTYPE: Mutations in this gene result in hyperglycemia and weight gain. [provided by MGI curators]
|Amino Acid Change||Valine changed to Glutamic Acid|
|Institutional Source||Beutler Lab|
|Gene Model||predicted gene model for protein(s): [ENSMUSP00000054776]|
AA Change: V65E
|Predicted Effect||probably damaging
PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|Meta Mutation Damage Score||0.732|
|Is this an essential gene?||Probably nonessential (E-score: 0.100)|
|Candidate Explorer Status||CE: excellent candidate; human score: 2; ML prob: 0.752|
Linkage Analysis Data
|Alleles Listed at MGI|
|Mode of Inheritance||Autosomal Recessive|
|Local Stock||Live Mice, Sperm, gDNA|
|Last Updated||2019-09-04 9:46 PM by Diantha La Vine|
|Record Created||2015-03-10 7:51 PM by Jeff SoRelle|
The chubby phenotype was identified among N-nitroso-N-ethylurea (ENU)-mutagenized G3 mice of the pedigree R1781, some of which showed higher body weights than wild-type and heterozygous littermates (Figure 1).
|Nature of Mutation|
Whole exome HiSeq sequencing of the G1 grandsire identified 97 mutations. The increased body weight phenotype was linked to a mutation in Mc4r: a T to A transversion at base pair 66,859,847 (v38) on chromosome 18, or base pair 641 in the GenBank genomic region NC_000084 encoding Mc4r. Linkage was found with a recessive model of inheritance (P = 1.101 x 10-8), wherein 1 variant homozygote departed phenotypically from 5 homozygous reference mice and 8 heterozygous mice (Figure 2). The mutation corresponds to residue 641 in the mRNA sequence NM_016977 within exon 1 of 1 total exons. The obesity phenotype observed in chubby mice mirrored that of other ENU-induced mutations attributed to Mc4r, including Southbeach and Fatboy (MGI:2671841) [Figure 3; (1)], confirming that the Mc4r mutation in chubby was causative.
The mutated nucleotide is indicated in red. The mutation results in a valine (V) to glutamic acid (E) substitution at position 65 (V65E) in the MC4R protein, and is strongly predicted by PolyPhen-2 to cause loss of function (score = 0.999).
MC4R belongs to the family of melanocortin receptors, which are seven transmembrane (TM) spanning G-protein coupled receptors (GPCRs) (Figure 3 & 4). MC4R activates the heterotrimeric G-protein Gs, which stimulates adenylyl cyclase production of cAMP from ATP (2). Based on a pure modeling approach modeled upon the crystal structure of bovine rhodopsin, another GPCR, residues in transmembrane domain (TM)3, TM4, TM5 and TM6 were predicted to flank the ligand binding site. Extracellular loops 2 and 3 also participate in docking of ligand (3). Interestingly, TM1 and TM7 were not predicted to contribute to ligand binding, although F284 was found at the edge of the ligand-binding pocket (3). The third intracellular loop of MC4R is predicted to form an α-helical segment, and play an important role in coupling the receptor to Gs. The chubby mutation causes a valine to glutamic acid substitution at amino acid 65 within TM1.
Please see the record for Southbeach for more information about Mc4r.
A main mechanism of energy balance regulation involves the control of signaling by the central melanocortin receptors (MCRs) MC3R and MC4R within a defined hypothalamic neural network. Two sets of neurons in the arcuate nucleus (a region surrounding the third ventricle in the most ventral portion of the hypothalamus) act as sensors of whole-body energy status and initiate signals to maintain energy stores at a constant level. The Agrp/Npy neurons (producing Agrp and neuropeptide Y) are inhibited by the leptin peptide (see the record for Potbelly) by signaling through the leptin receptor (see the record for Business_class), while Pomc/Cart neurons (producing Pomc; its proteolytic products and cocaine- and amphetamine-regulated transcript) are stimulated by leptin (4-6). Both Agrp/Npy and Pomc/Cart neurons synapse onto MC4R-expressing neurons (4;7). Thus, when leptin levels are low, Agrp/Npy neurons are activated and Pomc/Cart neurons are inhibited, producing Agrp but not Pomc, and resulting in inhibition of MC4R and increased food intake. In humans, mutations in MC4R are associated with obesity (OMIM #601665). Human patients with MC4R mutations exhibit increased body mass index, increased appetite, increased height, increased lean mass, increased bone mineral density and hyperinsulinemia (8). With the exception of increased bone mineral density, these phenotypes are recapitulated in Mc4r null mice (9). The localization, expression, and function of the MC4Rchubby protein have not been determined; however, the obesity phenotype of the chubby mice indicates that the mutation results in loss of MC4R function.
chubby(F):5'- TGCGAGCAAGGAGCTACAGATCAC -3'
chubby(R):5'- ACCCAGGAGGTTGGATCAGTTCAAG -3'
chubby_seq(F):5'- AGCTACAGATCACAGAGTCAATG -3'
chubby_seq(R):5'- TCAGTTCAAGGAGGACTCAAATC -3'
1) 94°C 2:00
The following sequence of 459 nucleotides is amplified (chromosome 18, - strand):
1 acccaggagg ttggatcagt tcaaggagga ctcaaatcca gctgctgcag gaagatgaac
Primer binding sites are underlined and the sequencing primers are highlighted; the mutated nucleotide is shown in red.
1. Meehan, T. P., Tabeta, K., Du, X., Woodward, L. S., Firozi, K., Beutler, B., and Justice, M. J. (2006) Point Mutations in the Melanocortin-4 Receptor Cause Variable Obesity in Mice. Mamm Genome. 17, 1162-1171.
2. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., and Yamada, T. (1993) Molecular Cloning, Expression, and Gene Localization of a Fourth Melanocortin Receptor. J Biol Chem. 268, 15174-15179.
3. Yang, X., Wang, Z., Dong, W., Ling, L., Yang, H., and Chen, R. (2003) Modeling and Docking of the Three-Dimensional Structure of the Human Melanocortin 4 Receptor. J Protein Chem. 22, 335-344.
4. Hahn, T. M., Breininger, J. F., Baskin, D. G., and Schwartz, M. W. (1998) Coexpression of Agrp and NPY in Fasting-Activated Hypothalamic Neurons. Nat Neurosci. 1, 271-272.
5. Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., Cone, R. D., and Low, M. J. (2001) Leptin Activates Anorexigenic POMC Neurons through a Neural Network in the Arcuate Nucleus. Nature. 411, 480-484.
6. Kristensen, P., Judge, M. E., Thim, L., Ribel, U., Christjansen, K. N., Wulff, B. S., Clausen, J. T., Jensen, P. B., Madsen, O. D., Vrang, N., Larsen, P. J., and Hastrup, S. (1998) Hypothalamic CART is a New Anorectic Peptide Regulated by Leptin. Nature. 393, 72-76.
7. Bagnol, D., Lu, X. Y., Kaelin, C. B., Day, H. E., Ollmann, M., Gantz, I., Akil, H., Barsh, G. S., and Watson, S. J. (1999) Anatomy of an Endogenous Antagonist: Relationship between Agouti-Related Protein and Proopiomelanocortin in Brain. J Neurosci. 19, RC26.
8. Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T., and O'Rahilly, S. (2003) Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene. N Engl J Med. 348, 1085-1095.
9. Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., Smith, F. J., Campfield, L. A., Burn, P., and Lee, F. (1997) Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice. Cell. 88, 131-141.
|Science Writers||Anne Murray|
|Authors||Jeff SoRelle, Jianhui Wang|